Polycystic kidney disease, autosomal dominant

[MIM 173 900600 666613 095]

(former name: adult polycystic disease)

Prevalence estimated at 1/1.000-1/2.500: it is the most common hereditary kidney diseases. The majority of cases (known as PKD1) are due to a mutation in the PKD1 gene (16p13) coding for polycystin 1; others are due to a mutation:



Cysts develop in a small percentage of nephrons from any part of the renal tubule. Radiological diagnostic criteria (so-called Ravine criteria) are: at least 2 cysts (on one kidney or a cyst in each kidney), patient under 30 years old / / 2 cysts in each kidney between 30 and 50 years old / / 4 cysts in each kidney over 59 years.

Usual form: the first symptoms appear between 30 and 40 years of age; only 20-40 % of patients progress to end-stage renal disease (dialysis).

Rare:  neonatal form with oligohydramnios, large kidneys and pulmonary hypoplasia (Potter syndrome).

In childhood: often asymptomatic; sometimes high blood pressure,  micro- or macroscopic hematuria, proteinuria, urinary infections, urolithiasis.


In adults:

-        intracranial aneurysms: 40 %  of the cases in case of PKD1 mutation: screening is recommended from the age of 15 years

-        mitral valve prolapse: 20-30 %

-        aortic  or cervical arteries aneurysm


Non-consistant and late hepatic involvement in 70 % of patients over the age of 60 years; occasionally associated with pancreatic cysts.


Anesthetic implications:

treatment of arterial hypertension; check renal function and electrolytes; avoid attacks of hypertension (cerebral aneurysm ?)


References : 


Updated: May 2021